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STUDY QUESTION: Does exposure to preconceptional hysterosalpingography (HSG) with iodinated oil-based contrast affect neonatal
thyroid function as compared to iodinated water-based contrast?
SUMMARY ANSWER: Preconceptional HSG with iodinated contrast did not influence the neonatal thyroid function.
WHAT IS KNOWN ALREADY: HSG is a commonly applied tubal patency test during fertility work-up in which either oil- or water-based
contrast is used. Oil-based contrast contains more iodine compared to water-based contrast. A previous study in an East Asian population
found an increased risk of congenital hypothyroidism (CH) in neonates whose mothers were exposed to high amounts of oil-based contrast
during HSG.
STUDYDESIGN, SIZE, DURATION:This is a retrospective data analysis of theH2Oil study, a randomized controlled trial (RCT) comparing
HSGwith the use of oil- versus water-based contrast during fertility work-up. After an HSGwith oil-based contrast, 214 women had an ongoing
pregnancy within 6 months leading to a live birth compared to 155 women after HSG with water-based contrast.
PARTICIPANTS/MATERIALS, SETTING, METHODS:Of the 369 women who had a live born infant, 208 consented to be approached
for future research and 138 provided informed consent to collect data on the thyroid function tests of their offspring (n= 140). Thyroid function
tests of these children were retrieved from the Dutch neonatal screening program, which includes the assessment of total thyroxine (T4) in
all newborns, followed by thyroid-stimulating hormone only in those with a T4 level of ≤−0.8 SD score. Furthermore, amount of contrast
medium used and time between HSG and conception were compared between the two study groups.
MAIN RESULTS AND THE ROLE OF CHANCE: Data were collected from 140 neonates conceived after HSG with oil-based (n= 76)
or water-based (n= 64) contrast. The median T4 concentration was 87.0 nmol/l [76.0–96.0] in the oil group and 90.0 nmol/l [78.0–106.0] in
the water group (P = 0.13). None of the neonates had a positive screening result for CH.
The median amount of contrast medium used was 9.0 ml [interquartile range (IQR), 6.0–11.8] in the oil-group and 10.0 ml [IQR, 7.5–14.0] in
the water group (P = 0.43). No influence of the amount of contrast on the effect of contrast group on T4 concentrations was found (P-value
for interaction, 0.37).
LIMITATIONS, REASONS FOR CAUTION: A relatively small sample size and possible attrition at follow-up are limitations of this study.
Although our results suggest that the use of iodinated contrast media for HSG is safe for the offspring, the impact of a decrease in maternal
thyroid function on offspring neurodevelopment could not be excluded, as data on maternal thyroid function after HSG and during conception
were lacking.
WIDER IMPLICATIONS OF THE FINDINGS: As HSG with oil-based contrast does not affect thyroid function of the offspring, there is
no reason to withhold this contrast to infertile women undergoing HSG. Future studies should investigate whether HSG with iodinated contrast
influences the periconceptional maternal thyroid function and, consequently, offspring neurodevelopment.
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Introduction
Hysterosalpingography (HSG), to assess tubal patency, is a standard
test during female fertility work-up. Although it was introduced as
a diagnostic tubal patency test, it recently became clear that HSG
increases ongoing pregnancy rates, especially after the use of oil-based
contrast (Fang et al., 2018; Wang et al., 2019). All contrast media
used for HSG are rich in iodine, with oil-based contrast containing
more iodine (480 mg Iodine/ml) than water-based contrast (ranging
from 240 to 300 mg Iodine/ml, depending on the manufacturer). In
addition, the clearance of oil-based contrast in the abdomen is slower
than that of water-based contrast (Brown et al., 1949; Miyamoto et al.,
1995).
Previous studies found that HSG resulted in a long-lasting sup-
pression of thyroid hormone synthesis in euthyroid women and,
even more profoundly, in women with subclinical hypothyroidism
(Mekaru et al., 2008; Kaneshige et al., 2015; So et al., 2017). Subclinical
hypothyroidism has been associated with an increased risk of preg-
nancy complications, including pre-eclampsia, perinatal mortality and
(recurrent) miscarriage (van den Boogaard et al., 2011; Korevaar et al.,
2019). Up until now two subsequent systematic reviews showed no
increased risk of miscarriage or stillbirth in women exposed to oil-
based contrast at HSG, which is reassuring (Fang et al., 2018; Wang
et al., 2019).
There is some evidence showing that maternal iodine excess due
to high dietary iodine intake or iodine-containing antiseptics may
put offspring at risk of congenital hypothyroidism (CH) (l’Allemand
et al., 1983; Nishiyama et al., 2004; Connelly et al., 2012; Hamby
et al., 2018). To date, surprisingly few studies have focused on the
impact of oil-based contrast during HSG on the neonatal thyroid
function; all of them were conducted in Asian populations, who
are known to consume diets rich in iodine. One study from Japan
reported a high risk of CH (of 2.4%, as compared to 0.7% in
the norm population) in neonates whose mothers were exposed
to high amounts of oil-based contrast medium during HSG (Satoh
et al., 2015). The other studies described associations between HSG
and the presence of fetal goiter or transient thyroid dysfunction
at birth, but not with permanent thyroid dysfunction (Omoto
et al., 2013; Sasaki et al., 2017). Indeed, neonates born to mothers
exposed to HSG had a higher urinary excretion of iodine (Li et al.,
2018).
We recently published the results of a large randomized controlled
trial (RCT; under the acronym H2Oil study) investigating the effects
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of oil- versus water-based contrast in women undergoing HSG as
part of fertility work-up on live birth rates, indicating that the first
was superior (Dreyer et al., 2017). The present study investigated the
thyroid function in their offspring at birth.
Materials and Methods
This is a retrospective data analysis of neonatal screening results
for CH in the offspring of mothers participating in the H2Oil study
who conceived within 6 months after HSG (NTR 3270). For this
purpose, neonatal screening results were retrieved from the Dutch
National Institute for Public Health and Environment (in Dutch:
Rijksinstituut voor Volksgezondheid en Milieu). This specific study
(NTR 7526) was approved by the institutional review board of
the Amsterdam University Medical Centre—VU University Medical
Centre, the Netherlands (reference 2018.463, dated 7 September
2018).
Participants
The H2Oil study is a multicenter RCT comparing oil-based contrast
(Lipiodol® Ultra Fluid, Guerbet France, containing 480 mg Iodine/ml)
with water-based contrast (Telebrix Hystero®, Guerbet France, con-
taining 250 mg Iodine/ml) in women undergoing HSG during fertility
work-up. Details of the H2Oil study have been published elsewhere
(Dreyer et al., 2017). Here, we only briefly describe the trial essen-
tials. Infertile women between 18 and 39 years of age with spon-
taneous menstrual cycles were included in the H2Oil study. Known
endocrine disorders (e.g. hyperthyroidism) were among the exclu-
sion criteria. No routine screening of the thyroid function was per-
formed.
A total of 1119 women were randomized to receive HSG with
oil-based contrast (n = 557) or water-based contrast (n = 562)
(Supplementary Figure S1). After HSG with oil-based contrast, within
6 months 214 women had an ongoing pregnancy leading to a live birth
compared to 155 women after HSG water-based contrast (Dreyer
et al., 2017). Of these women, 208 (56%) had given permission to be
approached for future research.
Parents were approached by postal mail, containing information
on this study. For the retrieval of the neonatal screening results,
both parents or legal guardians had to give written informed consent.
Additionally, they were also asked to provide additional information of
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Figure 1 Flowchart of the study.
the medical history of their child, including previous or current thyroid
hormone supplementation. Parents who did not respond within 2
weeks were sent a reminder.
Study outcomes
The main outcome was the neonatal total thyroxine (T4) concen-
tration (nmol/l). Other outcomes were, if available, concentrations
of thyroid-stimulating hormone (TSH) (mU/l) and thyroxine-binding
globulin (TBG) (nmol/l).
Statistical analysis
Demographic characteristics of the study population were compared
between the two study groups using the appropriate descriptive statis-
tics. Categorical data were reported as absolute numbers with percent-
ages (%)and continuous variables as medians with interquartile ranges
(IQRs). Dichotomous outcomes were compared using the χ 2 test and
continuous outcomes using the independent t-test or Mann–Whitney
U-test as appropriate. We tested whether amount of contrast or time
between HSG and conception modified the effect of contrast medium
on neonatal T4 concentration. Effect modification by amount of con-
trast was tested using a linear regression model with T4 concentration
as the dependent variable and amount of contrast, type of contrast (oil
versus water) and their two-way interaction as independent variables.
Effect modification by time between HSG and conception was tested
using ANOVA with T4 concentrations as the dependent variable
and time between HSG and conception, type of contrast (oil versus
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water) and their two-way interaction as independent variables. A P-
value less than 0.05 was considered statistically significant. Boxplot and
scatterplot were used to visualize the investigated associations. The
IBM Statistical Package for Social Sciences version 26.0 was used for all
statistical analyses (IBM Corp., USA).
Neonatal CH screening
The Dutch neonatal screening for CH is primarily based on T4 mea-
surement in filter paper blood spots obtained during the heel prick at
4 to 7 days after birth. Details of the Dutch CH screening program
have been described by (Kempers et al., 2006). In summary, T4
concentrations are expressed as standard deviation score (SDS) from
the daily mean. This is the standard screening procedure for CH in
the Netherlands (Verkerk et al., 2014). The daily means are used
instead of population reference means, to account for fluctuation in
laboratory measurements. If the T4 level is −0.8 SDS or less, the
TSH concentration is measured as well. This is accompanied by TBG
concentration when T4 is −1.6 SDS or less. Newborns with abnormal
screening results are immediately referred to a pediatrician. In case of
a dubious result, a second heel prick is performed, after which the child
is referred if the result is dubious again or abnormal.
Results
In the oil group, 75 (65.2%) of the 115 parents gave informed consent
to collect data on the thyroid function tests of their children (n = 76). In
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Table I Clinical data of neonates conceived after hysterosalpingography (HSG) with the use of oil- or water-based
contrast.
Neonates born after HSG with
.......................................................................................
Oil contrast (n = 76) Water contrast (n = 64) P-value
.....................................................................................................................................................................................
Gestational age (weeks) 39.7 [39.0–40.9] 39.6 [38.6–40.7] 0.27
Birthweighta (grams) 3470 [3115–3855] 3460 [3065–3721] 0.67
Sex
Male 38 (50) 30 (47) 0.71
Female 38 (50) 34 (53) -
Current use of thyroid hormones 0 (0) 0 (0) -
Neonatal screeningb
T4 (nmol/l) 87.0 [76.0–96.0] 90.0 [78.0–106.0] 0.13
T4 SDSc −0.05 [−0.5–0.5] 0.2 [−0.3–0.9] 0.12
Amount of contrast (milliliter)d 9.0 [6.0–11.8] 10.0 [7.5–14.0] 0.43
Iodine dose (grams)e 4.3 [2.9–5.7] 2.5 [1.9–3.5] 0.001
Duration between HSG and conception (months) 2.3 [1.1–4.3] 2.1 [1.1–4.0] 0.83
Duration between HSG and delivery (months) 11.1 [9.6–13.0] 10.7 [9.8–12.9] 0.73
Data presented as median [quartiles] or number of women (%).
aBirth weight was missing in one neonate in the water group.
bNeonatal screening result was missing in one neonate in the water group, due to neonatal screening abroad.
cThe concentration of T4 is expressed as standard deviation score (SDS) and is compared with the daily mean.
dAmount of contrast was missing in 32 in the oil group versus 39 women in the water group.
eThe calculated iodine dose is strictly correlated to the amount of contrast medium used (Lipiodol® 480 mg Iodine/ml and Telebrix Hystero® 250 mg Iodine/ml).
the water group, 63 (67.7%) of the 93 parents gave informed consent
to collect these data (n = 64; Fig. 1). The baseline characteristics
were comparable between the two groups (Supplementary Table SI).
Non-responders were not different from responders in baseline
characteristics.
None of the neonates conceived after HSG with oil- or water-
based contrast had a positive screening result for CH. Their data are
presented in Table I. T4 concentrations and T4 SDSs were comparable
between the two groups. None of the children were currently on
thyroid hormone supplementation.
The amount of contrast used for HSG was reported in 44 women
in the oil group versus 25 women in the water group. The median
amount of contrast was 9.0 ml [IQR, 6.0–11.8] in the oil group
and 10.0 ml [IQR, 7.5–14.0] in the water group (P =0.43). Linear
regression showed no influence of the amount of contrast on the effect
of the contrast group on T4 concentrations (P-value for interaction
0.37). Figure 2a and b depict the association of neonatal T4 concen-
trations with the amounts of oil-based or water-based contrast used
during HSG.
There was a significant difference in iodine dose between the
two contrast media used (4.3 grams [IQR, 2.9–5.7] versus 2.5 [IQR,
1.9–3.5]; P =0.001).
Time betweenHSG and conception was comparable between the oil
and water groups (2.3 months [IQR, 1.1–4.3] and 2.1 months [IQR,
1.1–4.0]; P =0.83). ANOVA showed no influence of time between
HSG and conception on the effect of the contrast group on T4
concentrations (P-value for interaction 0.47).
Consequently, time between HSG and delivery did not differ
between the two groups (11.1 months [IQR, 9.6–13.0] in the oil
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group versus 10.7 months [IQR, 9.8–12.9] in the water group; P-value
0.73).
However, in 13 neonates in the oil group and 7 neonates in the
water group, T4 SDSs were≤−0.8 and, therefore, TSHwas measured
(relative risk (RR), 1.5; 95% CI, 0.7–3.6; P =0.32). TSH concentrations
were within normal limits for all 20 neonates with T4 SDSs ≤−0.8. In
one neonate in the oil group, TBG was additionally measured. Both
TBG and T4/TBG ratio were within normal limits. Table II shows
no differences in the oil group in amount of contrast or duration
between HSG and conception among neonates with normal screening
results and those with T4 values ≤−0.8 SD, low enough to trig-
ger TSH testing. We found comparable results for the water group
(Table II).
Furthermore, no differences were seen in amount of contrast or
duration between HSG and conception within the neonates with
T4≤−0.8 SDS in the oil group versus the water group.
Discussion
In this study, we found that preconceptional exposure to an HSG with
oil-based or water-based contrast did not result in decreased thyroid
function in the offspring. In addition, we did not find an impact of the
amount of contrast used or the duration betweenHSG and conception
on neonatal T4 concentration between the treatment arms. Our
results are not in line with previous studies in East Asian populations.
A Japanese study found a higher frequency of thyroid dysfunction in
newborns conceived after HSG compared to normative data (2.4%
versus 0.7%; Satoh et al., 2015). In this study, mothers giving birth
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Figure 2 Association of neonatal T4 level with the amount of contrast used for (A) oil-based contrast and (B) water-based
contrast. The scatterplots show the association of neonatal T4 concentrations with the amount of (A) oil-based contrast versus (B) water-based
contrast used during HSG. Both scatterplots show the linear regression lines (solid lines) with their uncertainty (dotted lines).
Table II Clinical data of neonates with normal T4 or T4−0.8 SD in the oil (n = 76) and water (n = 64) group.
Neonates in the oil group Neonates in the water group
........................................................... ........................................................
Normal T4
>− 0.8 SD
(n=63)
T4
≤− 0.8 SD
(n=13)
P-value
Normal T4
>− 0.8 SD
(n=56)
T4
≤− 0.8 SD
(n=7)
P-value
.....................................................................................................................................................................................
Neonatal screening
T4 (nmol/l) 88.0 [81.0–102.0] 61.0 [54.5–70.5] - 92.0 [84.0–106.0] 68.0 [63.0–71.0] -
T4 SDSf 0.2 [−0.2–0.7] −1.1 [−1.4−−0.9] - 0.3 [−0.2–1.0] -0.9[−1.1– −0.8] -
TSHg (mU/l) - 2.0 [1.0–2.5] - - 1.0 [1.0–2.0] -
Amount of contrast (ml)h 9.0 [6.0–11.0] 10.0 [6.3–20.0] 0.53 10.0 [7.0–14.0] 8.0 [8.0–11.5] 1.00
Iodine dose (grams)i 4.3 [2.9–5.3] 4.8 [3.0–9.6] 0.53 2.5 [1.7–3.5] 2.0 [2.0–2.9] 1.00
Duration between HSG and conception (months) 2.4 [1.1–4.5] 1.9 [0.7–3.5] 0.36 2.2 [1.1–4.1] 1.9 [1.2–2.9] 0.58
Duration between HSG and delivery (months) 11.2 [9.6–13.3] 10.8 [9.1–12.1] 0.16 10.9 [9.8–13.0] 10.6 [9.7–11.6] 0.56
Data presented as median [quartiles].
f The concentration of T4 is expressed as SDS and is compared with the daily mean.
gT4 values ≤ − 0.8 SD, low enough to trigger TSH testing.
hAmount of contrast was missing in 26 versus 6 women in the oil-group and 35 versus 4 women in the water-group.
iThe calculated iodine dose is strictly correlated to the amount of contrast medium used (Lipiodol® 480 mg Iodine/ml and Telebrix Hystero® 250 mg Iodine/ml).
to offspring with thyroid dysfunction had been exposed to a higher
amount of contrast duringHSG (median of 20ml versus 8ml), although
used amount was only available for 112 out of 212 neonates with
normal thyroid function and for 3 out of 5 neonates with thyroid
dysfunction (Satoh et al., 2015). To the best of our knowledge, only
two Japanese cases with fetal goiter after maternal HSGwere reported
(Omoto et al., 2013; Sasaki et al., 2017), although according to Omoto
et al. (2013) ‘at least 17 cases of transient hypothyroidism in a fetus
after HSG have been reported in Japanese literature since 1990’. In one
of these fetuses, the goiter resolved during pregnancy and the thyroid
function tests were normal at birth (Sasaki et al., 2017). In the other
the fetal goiter persisted and overt hypothyroidism was noted at birth.
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This was followed by a spontaneous resolution of the goiter by 4 weeks
post-partum along with normalization of thyroid function tests in the
preceding weeks (Omoto et al., 2013). None of the children in our
sample were diagnosed with goiter as newborns.
As stated earlier, all studies conducted thus far were limited to East
Asian populations. There is a striking difference in background risk for
CH between Japan and theNetherlands, i.e. 0.7% in Japan versus 0.05%
in the Netherlands (Tokyo Health Service Association, 2010; Dutch
National Institute for Public Health and Environment, 2014). Among
the possible explanations for this difference is the high consumption of
iodine-rich foods (i.e. seaweed) in Japan. It has been estimated that the
iodine intake of pregnant women in Japan is approximately 3–4 times as
D
ow
nloaded from
 https://academ
ic.oup.com
/hum
rep/article-abstract/35/5/1159/5840459 by U
niversity of Aberdeen user on 09 July 2020
1164 van Welie et al.
high as theWorld healthOrganization recommendation (WorldHealth
Organization, 2007; Fuse et al., 2013).
Strengths and limitations
The current study has several strengths and limitations. The major
strengths are that this study was based on a large multicenter RCT
and had included a large majority of Caucasian women. Additionally, in
contrast to other countries, which generally have TSH-based screening
programs, the Dutch neonatal screening program for CH is T4-TSH-
TBG based, being able to detect CH of both central and thyroidal
origin. The amount of contrast used during HSG was reported, instead
of the calculated iodine dose, as the amount of contrast is relevant for
clinicians in daily practice and iodine dose is strictly correlated to the
amount of contrast used.
Limitations of our study are the relatively small sample size and
attrition at follow-up. This might obscure a possible relation between
the type of contrast medium and the presence of CH if women
with excessive iodine exposure selectively declined to participate.
However, a non-response analysis showed that responders and non-
responders did not differ in a number of the baseline characteristics,
implicating that non-response bias is unlikely to have materially influ-
enced our observations, although the amount of contrast used was
not known from all participants. The H2Oil RCT was not powered
to study the safety in neonates of the different types of iodinated
contrast media during HSG. Nonetheless, data regarding the neona-
tal thyroid function are reliable even though they were collected
retrospectively.
Furthermore, only offspring conceived within 6 months after HSG
were included (Dreyer et al., 2017). Offspring conceived between
6 months and 5 years after HSG, who also took part in the H2Oil
follow-up study, were not contacted for this specific study (van Rijswijk
et al., 2018). It is unlikely that iodinated contrast could still affect the
offspring’s thyroid function when more time than 6 months has elapsed
between HSG and conception (Kaneshige et al., 2015; So et al., 2017).
Our study did not include an assessment of the maternal thyroid
function after HSG or during conception. Consequently, it was impos-
sible to study the impact of a decrease in the maternal thyroid function
on offspring neurodevelopment. Studies in East Asian populations
demonstrated that HSG could result in a long-lasting suppression
in thyroid hormone synthesis in euthyroid women and, even more
profoundly, in women with subclinical hypothyroidism (Mekaru et al.,
2008; Kaneshige et al., 2015; So et al., 2017). Furthermore, the use
of iodine-rich products preconceptionally during pregnancy or after
delivery was not registered, which could potentially influence our
findings.
Implications
Overexposure to iodine may result in a sudden cessation of thyroid
hormone synthesis, a phenomenon called the Wolff–Chaikoff effect
(Eng et al., 1999). This protective mechanism works for a couple of
days, after which thyroid hormone synthesis is resumed. However,
during prolonged exposure to excess iodine, the thyroid gland is unable
to escape from the Wolff–Chaikoff effect, resulting in a long-lasting
suppression of thyroid hormone synthesis (Wolff et al., 1949; Markou
et al., 2001; Leung and Braverman, 2012).
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From the second trimester of pregnancy the fetal thyroid gland
starts to produce thyroid hormones. Therefore, during early embry-
onic development the fetal brain depends entirely on the supply of
maternal thyroid hormones (Contempre et al., 1993; Burrow et al.,
1994). Consequently, overexposure to iodine may not only disrupt
fetal brain development through inhibition of fetal thyroid hormone
synthesis but also through its effects on the maternal thyroid gland.
This is suggested by an increasing body of evidence demonstrating that
children born to mothers with decreased thyroid function during the
first half of pregnancy had reductions in the achievement of devel-
opmental milestones, IQ score, reaction time, scholastic performance
and attention, although the evidence was not unequivocal (Haddow
et al., 1999; Pop et al., 1999; Smit et al., 2000; Pop et al., 2003; Oken
et al., 2009; Henrichs et al., 2010; Li et al., 2010; Craig et al., 2012;
Noten et al., 2015; Oostenbroek et al., 2017; Thompson et al., 2018).
Therefore, monitoring of the maternal thyroid function after HSG
might seem warranted, but at this point no definite conclusion can
be drawn.
Conclusion
In contrast to previous research in East Asian populations, we found
that preconceptional HSG with iodinated contrast did not influence
neonatal thyroid function. Although this suggests that iodinated con-
trast media are safe for the offspring, indirect effects on neurodevel-
opment (through inhibition of maternal thyroid hormone synthesis)
could not be excluded and warrant further investigation. Meanwhile,
there is no reason to withhold HSG with oil-based contrast to infertile
women. We recommend keeping the amount of contrast used as low
as possible.
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Supplementary data are available at Human Reproduction online.
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